<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:32:30Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/22113" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/22113</identifier><datestamp>2026-09-24T07:12:48Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Verdu, Elena</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">McCarville, Justin</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2017-10-05T15:07:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2017-10-05T15:07:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2017-11</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/22113</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/24182</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Celiac disease is a chronic atrophic enteropathy triggered by the ingestion of&#xd;
dietary gluten in genetically predisposed individuals expressing HLA class II genes, DQ2&#xd;
or DQ8. Both innate and adaptive immune mechanisms are required for the development&#xd;
of the disease. The adaptive immune response is well characterized and includes the&#xd;
development of gluten-specific T-cells and antibodies towards gluten and the autoantigen,&#xd;
tissue transglutaminase 2. Less is known about the initiation of the innate immune&#xd;
response and its triggers, which is characterized by increases in cytokines such as IL-15,&#xd;
leading to proliferation and cytotoxic transformation of intraepithelial lymphocytes that&#xd;
are not specific to gluten. Although genetic susceptibility is necessary for celiac disease&#xd;
and present in 30% of most populations, only about 1% will develop it. This points to&#xd;
additional environmental factors, which could be microbial in origin. Disruptions of the&#xd;
gut microbial ecosystem, termed the intestinal microbiota, have been associated with the&#xd;
development and severity of many gastrointestinal disorders. Indeed, compositional&#xd;
differences in fecal and small intestinal microbiota have been described in patients with&#xd;
active celiac disease compared to healthy controls. This “dysbiosis” includes increases in&#xd;
small intestinal Proteobacteria and reductions in Firmicutes, but mechanistic information&#xd;
is lacking. Our lab has previously demonstrated that patients with active celiac disease&#xd;
have decreased expression of the serine protease inhibitor elafin in the duodenal mucosa,&#xd;
suggesting that proteolytic imbalance from either host or microbial origin, could be&#xd;
important in disease pathogenesis. The aim of this thesis is to study mechanisms through&#xd;
which the intestinal microbiota may contribute to the development of gluten sensitivity. I thus hypothesized that the proteolytic capacity of a dysbiotic small intestinal microbiota&#xd;
could promote the development of gluten sensitivity, in a genetically susceptible host.&#xd;
Firstly, I investigated whether the intestinal microbiota is a source of proteases in the gut&#xd;
lumen, that metabolize gluten in vivo affecting its immunogenicity. Secondly, I studied&#xd;
whether and how bacterial proteases stimulate innate immune mechanisms, relevant to&#xd;
celiac disease pathogenesis. Last, I investigated whether some of these mechanisms could&#xd;
be targeted to improve gluten sensitivity.&#xd;
In Chapter 3 of this thesis, I show that the small intestinal microbiota participates&#xd;
in gluten metabolism in vivo in mice. Proteobacteria and opportunistic pathogen&#xd;
Pseudomonas aeruginosa, isolated from patients with celiac disease, metabolize gluten&#xd;
proteins through microbial elastase. Bacterially-modified gluten peptides translocate the&#xd;
mucosal barrier with efficiency and retain immunostimulatory capacity when incubated&#xd;
with gluten-specific T-cells from patients with celiac disease. However, bacteria found in&#xd;
higher abundance in healthy individuals, such as Lactobacilli, metabolize P. aeruginosa modified gluten peptides reducing their antigenicity. This constitutes an opportunistic&#xd;
pathogen-gluten-host mechanism that could modulate celiac disease risk in genetically&#xd;
susceptible people.&#xd;
In Chapter 4, I show that bacterial proteases capable of extracellularly&#xd;
metabolizing gluten, such as P. aeruginosa elastase, also have the capacity to stimulate&#xd;
innate immune responses in the small intestine, likely through a protease activated&#xd;
receptor-2-dependent mechanism. This innate immune response does not require HLArisk&#xd;
genes and is characterized by non-specific increases in small intestinal intraepithelial lymphocytes. In mice transgenic for the HLA-DQ8 gene, the presence of P. aeruginosa&#xd;
elastase in the small intestine exacerbates gluten-induced pathology.&#xd;
In Chapter 5, I use a commensal Bifidobacterium longum strain that naturally&#xd;
produces a serine protease inhibitor, with the ability to inhibit elastase activity. I show&#xd;
that administration of Bifidobacterium longum to mice expressing the HLA-DQ8 gene&#xd;
prevents gluten immunopathology. The effect is dependent on the production of the&#xd;
bacterial serine protease inhibitor, as it was not observed with a B. longum knock-out for&#xd;
the serine protease inhibitor gene. Within this thesis, I demonstrate that microbial&#xd;
proteases can modulate gluten sensitivity through participation in both adaptive and&#xd;
innate immune pathways using celiac disease as a model of gastrointestinal disease.&#xd;
Further, I provide pre-clinical support that this pathway can be targeted for therapeutic&#xd;
purposes using protease inhibitors from commensal bacterial strains. My results provide&#xd;
causal evidence and novel mechanisms through which small intestinal bacteria may&#xd;
exacerbate or attenuate gluten sensitivity.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">A ROLE FOR BACTERIAL-DERIVED PROTEASES AND PROTEASE INHIBITORS IN FOOD SENSITIVITY.</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>